Rift Valley Fever – epidemiological update and risk of introduction into Europe

Abstract Rift Valley fever (RVF) is a vector‐borne disease transmitted by a broad spectrum of mosquito species, especially Aedes and Culex genus, to animals (domestic and wild ruminants and camels) and humans. Rift Valley fever is endemic in sub‐Saharan Africa and in the Arabian Peninsula, with periodic epidemics characterised by 5–15 years of inter‐epizootic periods. In the last two decades, RVF was notified in new African regions (e.g. Sahel), RVF epidemics occurred more frequently and low‐level enzootic virus circulation has been demonstrated in livestock in various areas. Recent outbreaks in a French overseas department and some seropositive cases detected in Turkey, Tunisia and Libya raised the attention of the EU for a possible incursion into neighbouring countries. The movement of live animals is the most important pathway for RVF spread from the African endemic areas to North Africa and the Middle East. The movement of infected animals and infected vectors when shipped by flights, containers or road transport is considered as other plausible pathways of introduction into Europe. The overall risk of introduction of RVF into EU through the movement of infected animals is very low in all the EU regions and in all MSs (less than one epidemic every 500 years), given the strict EU animal import policy. The same level of risk of introduction in all the EU regions was estimated also considering the movement of infected vectors, with the highest level for Belgium, Greece, Malta, the Netherlands (one epidemic every 228–700 years), mainly linked to the number of connections by air and sea transports with African RVF infected countries. Although the EU territory does not seem to be directly exposed to an imminent risk of RVFV introduction, the risk of further spread into countries neighbouring the EU and the risks of possible introduction of infected vectors, suggest that EU authorities need to strengthen their surveillance and response capacities, as well as the collaboration with North African and Middle Eastern countries.

[1]  F. Schaffner,et al.  RVF vector spatial distribution models: Probability of presence , 2020, EFSA Supporting Publications.

[2]  M. Krit,et al.  Assessment of the probability of entry of Rift Valley fever virus into the EU through active or passive movement of vectors , 2020, EFSA Supporting Publications.

[3]  P. Müller,et al.  Active dispersal of Aedes albopictus: a mark-release-recapture study using self-marking units , 2019, Parasites & Vectors.

[4]  Don R. Reynolds,et al.  Windborne long-distance migration of malaria mosquitoes in the Sahel , 2019, Nature.

[5]  J. Héraud,et al.  Development and validation of a pen side test for Rift Valley fever , 2019, PLoS neglected tropical diseases.

[6]  D. S. McVey,et al.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen , 2019, Journal of Clinical Microbiology.

[7]  S. Hales,et al.  Intercepted Mosquitoes at New Zealand’s Ports of Entry, 2001 to 2018: Current Status and Future Concerns , 2019, Tropical medicine and infectious disease.

[8]  P. Marianneau,et al.  A DNA Vaccine Encoding the Gn Ectodomain of Rift Valley Fever Virus Protects Mice via a Humoral Response Decreased by DEC205 Targeting , 2019, Front. Immunol..

[9]  E. Rybicki,et al.  Chimaeric Rift Valley Fever Virus-Like Particle Vaccine Candidate Production in Nicotiana benthamiana. , 2019, Biotechnology journal.

[10]  C. King,et al.  The influence of raw milk exposures on Rift Valley fever virus transmission , 2019, PLoS neglected tropical diseases.

[11]  B. Lubisi,et al.  Evaluation of a Virus Neutralisation Test for Detection of Rift Valley Fever Antibodies in Suid Sera , 2019, Tropical medicine and infectious disease.

[12]  G. Bettinger,et al.  Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves. , 2019, Vaccine.

[13]  R. Kading,et al.  Can Bats Serve as Reservoirs for Arboviruses? , 2019, Viruses.

[14]  Y. Helmy,et al.  The One Health Approach is Necessary for the Control of Rift Valley Fever Infections in Egypt: A Comprehensive Review , 2019, Viruses.

[15]  G. Bettinger,et al.  Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania , 2019, The Onderstepoort journal of veterinary research.

[16]  M. Groschup,et al.  Productive Propagation of Rift Valley Fever Phlebovirus Vaccine Strain MP-12 in Rousettus aegyptiacus Fruit Bats , 2018, Viruses.

[17]  D. S. McVey,et al.  Susceptibility of White-Tailed Deer to Rift Valley Fever Virus , 2018, Emerging infectious diseases.

[18]  B. Súdre,et al.  Early start of the West Nile fever transmission season 2018 in Europe , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[19]  S. Gubbins,et al.  Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016 , 2018, PLoS neglected tropical diseases.

[20]  M. Forzan,et al.  Rift Valley fever virus: a serological survey in Libyan ruminants , 2018, Open veterinary journal.

[21]  M. Baylis,et al.  Survey of UK horse owners’ knowledge of equine arboviruses and disease vectors , 2018, Veterinary Record.

[22]  J. Beier,et al.  Rift Valley Fever in Egypt and other African countries: Historical review, recent outbreaks and possibility of disease occurrence in Egypt. , 2018, Acta tropica.

[23]  L. Nyakarahuka,et al.  Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations , 2018, PLoS neglected tropical diseases.

[24]  Ashley E. Piper,et al.  Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates , 2018, PLoS neglected tropical diseases.

[25]  L. Nyakarahuka,et al.  Prevalence and risk factors of Rift Valley fever in humans and animals from Kabale district in Southwestern Uganda, 2016 , 2018, PLoS neglected tropical diseases.

[26]  E. Koonin,et al.  Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018 , 2018, Archives of Virology.

[27]  E. Albina,et al.  Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins. , 2018, Veterinary immunology and immunopathology.

[28]  M. Crabtree,et al.  Neutralizing antibodies against flaviviruses, Babanki virus, and Rift Valley fever virus in Ugandan bats , 2018, Infection ecology & epidemiology.

[29]  P. Calistri,et al.  Understanding the legal trade of cattle and camels and the derived risk of Rift Valley Fever introduction into and transmission within Egypt , 2018, PLoS neglected tropical diseases.

[30]  Alexander N. Freiberg,et al.  Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain. , 2017, Vaccine.

[31]  N. Busquets,et al.  Rift Valley fever virus and European mosquitoes: vector competence of Culex pipiens and Stegomyia albopicta (= Aedes albopictus) , 2017, Medical and veterinary entomology.

[32]  M. Groschup,et al.  Rift Valley fever virus infections in Egyptian cattle and their prevention , 2017, Transboundary and emerging diseases.

[33]  F. Bartumeus,et al.  Direct Evidence of Adult Aedes albopictus Dispersal by Car , 2017, Scientific Reports.

[34]  E. Ahmadi,et al.  The first positive serological study on rift valley fever in ruminants of Iran , 2017, Journal of vector borne diseases.

[35]  J. Pawęska,et al.  A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test. , 2017, Journal of virological methods.

[36]  N. Erol,et al.  The first serological evidence for Rift Valley fever infection in the camel, goitered gazelle and Anatolian water buffaloes in Turkey , 2017, Tropical Animal Health and Production.

[37]  N. Osterrieder,et al.  An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep , 2017, Virology Journal.

[38]  D. Borras,et al.  Modelling the range expansion of the Tiger mosquito in a Mediterranean Island accounting for imperfect detection , 2017, Frontiers in Zoology.

[39]  A. Tatem,et al.  Mosquitoes on a plane: Disinsection will not stop the spread of vector-borne pathogens, a simulation study , 2017, PLoS neglected tropical diseases.

[40]  T. Ikegami Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate , 2017, Expert review of vaccines.

[41]  M. Keeling,et al.  Absence of Evidence of Rift Valley Fever Infection in Eulemur fulvus (Brown Lemur) in Mayotte During an Interepidemic Period , 2017, Vector borne and zoonotic diseases.

[42]  N. Johnson,et al.  Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes. , 2017, The Journal of general virology.

[43]  S. More,et al.  Vector‐borne diseases , 2017, EFSA journal. European Food Safety Authority.

[44]  M. Braks,et al.  Risk of vector‐borne diseases for the EU: Entomological aspects: Part 2 , 2017 .

[45]  R. Sang,et al.  Distribution and abundance of key vectors of Rift Valley fever and other arboviruses in two ecologically distinct counties in Kenya , 2017, PLoS neglected tropical diseases.

[46]  M. Groschup,et al.  Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania , 2016, Epidemiology and Infection.

[47]  A. Ripani,et al.  Review of the foot and mouth disease situation in North Africa and the risk of introducing the disease into Europe. , 2016, Revue scientifique et technique.

[48]  J. Charlier,et al.  DISCONTOOLS: a database to identify research gaps on vaccines, pharmaceuticals and diagnostics for the control of infectious diseases of animals , 2016, BMC Veterinary Research.

[49]  D. Calavas,et al.  Identifying Areas Suitable for the Occurrence of Rift Valley Fever in North Africa: Implications for Surveillance. , 2016, Transboundary and emerging diseases.

[50]  M. Ennaji,et al.  Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels , 2016, BMC Veterinary Research.

[51]  Jay P. Kiser,et al.  The hitchhiker's guide to becoming invasive: exotic mosquitoes spread across a US state by human transport not autonomous flight , 2016, Molecular ecology.

[52]  D. S. McVey,et al.  A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep , 2016, Scientific Reports.

[53]  S. Makino,et al.  Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates. , 2016, Virus research.

[54]  M. Yahia Saudi Arabia , 2016, Nature.

[55]  S. Makino,et al.  Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine. , 2016, Methods in molecular biology.

[56]  A. Anyamba,et al.  Rift Valley Fever: An Emerging Mosquito-Borne Disease. , 2016, Annual review of entomology.

[57]  V. Moulin,et al.  Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths , 2016, PLoS neglected tropical diseases.

[58]  M. Calzolari Mosquito-borne diseases in Europe: an emerging public health threat , 2016 .

[59]  V. Nene,et al.  Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever , 2016, Scientific Reports.

[60]  J. Delgado,et al.  Review of ten-years presence of Aedes albopictus in Spain 2004–2014: known distribution and public health concerns , 2015, Parasites & Vectors.

[61]  Ali S Khan,et al.  The Risk of Nosocomial Transmission of Rift Valley Fever , 2015, PLoS neglected tropical diseases.

[62]  A. Conte,et al.  First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region , 2015, PloS one.

[63]  R. Hewson,et al.  Serologic evidence of exposure to Rift Valley fever virus detected in Tunisia , 2015, New microbes and new infections.

[64]  M. Ennaji,et al.  Evaluation of the Safety and Efficacy of a Live Attenuated Thermostable RiftValley Fever Vaccine in Sheep, Goats and Cattle , 2015 .

[65]  A. Grout ‘To Spray or Not to Spray’: Developing a Tourism-Linked Research Agenda for Aircraft Disinsection , 2015, European Journal of Tourism Research.

[66]  F. Simard,et al.  The Spread of Aedes albopictus in Metropolitan France: Contribution of Environmental Drivers and Human Activities and Predictions for a Near Future , 2015, PloS one.

[67]  Luciano M Tantely,et al.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar. , 2015, The American journal of tropical medicine and hygiene.

[68]  J. Pawęska,et al.  Randomized Controlled Field Trial to Assess the Immunogenicity and Safety of Rift Valley Fever Clone 13 Vaccine in Livestock , 2015, PLoS neglected tropical diseases.

[69]  B. Bett,et al.  A systematic review of Rift Valley Fever epidemiology 1931–2014 , 2015, Infection ecology & epidemiology.

[70]  R. Lancelot,et al.  Comprehensive phylogenetic reconstructions of Rift Valley fever virus: the 2010 northern Mauritania outbreak in the Camelus dromedarius species. , 2014, Vector borne and zoonotic diseases.

[71]  Louise Taylor,et al.  OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals , 2014 .

[72]  B. Bosch,et al.  Comparative efficacy of two next-generation Rift Valley fever vaccines. , 2014, Vaccine.

[73]  F. Rodríguez,et al.  Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs. , 2014, Antiviral research.

[74]  R. Bellini,et al.  A review of the vector management methods to prevent and control outbreaks of West Nile virus infection and the challenge for Europe , 2014, Parasites & Vectors.

[75]  D. Wallace,et al.  Validation of an ELISA for the concurrent detection of total antibodies (IgM and IgG) to Rift Valley fever virus. , 2014, The Onderstepoort journal of veterinary research.

[76]  J. Pawęska,et al.  Macroarray assay for differential diagnosis of meningoencephalitis in southern Africa. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[77]  G. Bettinger,et al.  Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep. , 2014, Vaccine.

[78]  M. Thrusfield,et al.  Evidence of rift valley fever seroprevalence in the Sahrawi semi-nomadic pastoralist system, Western Sahara , 2014, BMC Veterinary Research.

[79]  Sunny E. Townsend,et al.  The changing landscape of rabies epidemiology and control , 2014, The Onderstepoort journal of veterinary research.

[80]  T. Hance,et al.  Invasive Process and Repeated Cross-Sectional Surveys of the Mosquito Aedes japonicus japonicus Establishment in Belgium , 2014, PloS one.

[81]  P. Verdonschot,et al.  Flight distance of mosquitoes (Culicidae): A metadata analysis to support the management of barrier zones around rewetted and newly constructed wetlands , 2014 .

[82]  C. Rowe,et al.  Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study , 2014, PloS one.

[83]  Michael G Kaufman,et al.  Invasion biology of Aedes japonicus japonicus (Diptera: Culicidae). , 2014, Annual review of entomology.

[84]  J. Coetzer,et al.  Sensitivity and specificity of real-time reverse transcription polymerase chain reaction, histopathology, and immunohistochemical labeling for the detection of Rift Valley fever virus in naturally infected cattle and sheep , 2014, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[85]  M. Rhaymah,et al.  Seroprevelance study of Rift Valley fever antibody in sheep and goats in Ninevah governorate. , 2013 .

[86]  A. Hill,et al.  Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice , 2013, Virology Journal.

[87]  C Ippoliti,et al.  A geographical information system-based multicriteria evaluation to map areas at risk for Rift Valley fever vector-borne transmission in Italy. , 2013, Transboundary and Emerging Diseases.

[88]  H. Weingartl,et al.  Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments. , 2013, Journal of virological methods.

[89]  R. Moormann,et al.  A Single Vaccination with an Improved Nonspreading Rift Valley Fever Virus Vaccine Provides Sterile Immunity in Lambs , 2013, PloS one.

[90]  M. Groschup,et al.  A novel indirect ELISA based on glycoprotein Gn for the detection of IgG antibodies against Rift Valley fever virus in small ruminants. , 2013, Research in veterinary science.

[91]  V. Chevalier,et al.  Towards a better understanding of Rift Valley fever epidemiology in the south-west of the Indian Ocean , 2013, Veterinary Research.

[92]  M. Groschup,et al.  A Single Immunization with MVA Expressing GnGc Glycoproteins Promotes Epitope-specific CD8+-T Cell Activation and Protects Immune-competent Mice against a Lethal RVFV Infection , 2013, PLoS neglected tropical diseases.

[93]  M. Bouloy,et al.  Vaccination for the control of Rift Valley fever in enzootic and epizootic situations. , 2013, Developments in biologicals.

[94]  G. Hendrickx,et al.  Abundance of Rift Valley Fever vectors in Europe and the Mediterranean Basin , 2013 .

[95]  R. Bellini,et al.  Pilot Field Trials with Aedes albopictus Irradiated Sterile Males in Italian Urban Areas , 2013, Journal of medical entomology.

[96]  R. K. Muhsen Seroepidemiology of Rift Valley Fever in Basrah , 2012, Kufa Journal For Veterinary Medical Sciences.

[97]  J. Pawęska,et al.  Comparison of a recombinant nucleocapsid IgG indirect ELISA with an IgG sandwich ELISA for the detection of antibodies to Rift Valley fever virus in small ruminants. , 2012, Vector borne and zoonotic diseases.

[98]  Å. Lundkvist,et al.  Stability of a formalin-inactivated Rift Valley fever vaccine: evaluation of a vaccination campaign for cattle in Mozambique. , 2012, Vaccine.

[99]  A. Pyke,et al.  Evidence in Australia for a Case of Airport Dengue , 2012, PLoS neglected tropical diseases.

[100]  A. Tatem,et al.  Web-based GIS: the vector-borne disease airline importation risk (VBD-AIR) tool , 2012, International Journal of Health Geographics.

[101]  F. Hufert,et al.  Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[102]  M. Bouloy,et al.  MBT/Pas mouse: a relevant model for the evaluation of Rift Valley fever vaccines. , 2012, The Journal of general virology.

[103]  H. Zeller,et al.  A review of the invasive mosquitoes in Europe: ecology, public health risks, and control options. , 2012, Vector borne and zoonotic diseases.

[104]  S. D. Boer,et al.  Efficacy of three candidate Rift Valley fever vaccines in sheep. , 2012, Vaccine.

[105]  S. Fukushi,et al.  The Dominant-Negative Inhibition of Double-Stranded RNA-Dependent Protein Kinase PKR Increases the Efficacy of Rift Valley Fever Virus MP-12 Vaccine , 2012, Journal of Virology.

[106]  A. Adkin,et al.  Assessing the risks of West Nile virus-infected mosquitoes from transatlantic aircraft: implications for disease emergence in the United Kingdom. , 2012, Vector borne and zoonotic diseases.

[107]  S. Goodman,et al.  THE ROLE OF WILD MAMMALS IN THE MAINTENANCE OF RIFT VALLEY FEVER VIRUS , 2012, Journal of wildlife diseases.

[108]  A. Tatem,et al.  Air travel and vector-borne disease movement , 2012, Parasitology.

[109]  H. Yoo,et al.  Competitive ELISA for the detection of antibodies to Rift Valley fever virus in goats and cattle. , 2012, The Journal of veterinary medical science.

[110]  S. Nichol,et al.  Single-Dose Immunization with Virus Replicon Particles Confers Rapid Robust Protection against Rift Valley Fever Virus Challenge , 2012, Journal of Virology.

[111]  R. Sang,et al.  Field Evaluation of A Wicking Assay for the Rapid Detection of Rift Valley Fever Viral Antigens In Mosquitoes1 , 2011, Journal of the American Mosquito Control Association.

[112]  S. Kamal Observations on rift valley fever virus and vaccines in Egypt , 2011 .

[113]  J. Figuerola,et al.  Rift Valley and West Nile Virus Antibodies in Camels, North Africa , 2011, Emerging infectious diseases.

[114]  J. Pawęska,et al.  Molecular Epidemiology of Rift Valley Fever Virus , 2011, Emerging infectious diseases.

[115]  D. Wallace,et al.  Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus. , 2011, Journal of virological methods.

[116]  A. McElroy,et al.  Rift Valley Fever Virus Vaccine Lacking the NSs and NSm Genes Is Safe, Nonteratogenic, and Confers Protection from Viremia, Pyrexia, and Abortion following Challenge in Adult and Pregnant Sheep , 2011, Journal of Virology.

[117]  S. de la Rocque,et al.  Unexpected Rift Valley Fever Outbreak, Northern Mauritania , 2011, Emerging infectious diseases.

[118]  Viviana Cobos-Jiménez,et al.  Creation of a Nonspreading Rift Valley Fever Virus , 2011, Journal of Virology.

[119]  A. Brault,et al.  Recombinant Rift Valley fever vaccines induce protective levels of antibody in baboons and resistance to lethal challenge in mice , 2011, Proceedings of the National Academy of Sciences.

[120]  C. Peters,et al.  Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine. , 2011, The Journal of infectious diseases.

[121]  M. Bouloy,et al.  Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves. , 2011, Vaccine.

[122]  C. Peters,et al.  Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus. , 2011, The Journal of infectious diseases.

[123]  M. Turell,et al.  Wicking Assay for the Rapid Detection of Rift Valley Fever Viral Antigens in Mosquitoes (Diptera: Culicidae) , 2011, Journal of medical entomology.

[124]  N. Knowles,et al.  Combining livestock trade patterns with phylogenetics to help understand the spread of foot and mouth disease in sub-Saharan Africa, the Middle East and Southeast Asia. , 2011, Revue scientifique et technique.

[125]  C. King,et al.  Arbovirus Prevalence in Mosquitoes, Kenya , 2011, Emerging infectious diseases.

[126]  F. Rurangirwa,et al.  Protection of Sheep against Rift Valley Fever Virus and Sheep Poxvirus with a Recombinant Capripoxvirus Vaccine , 2010, Clinical and Vaccine Immunology.

[127]  J. Pawęska,et al.  Comparison of enzyme-linked immunosorbent assay-based techniques for the detection of antibody to Rift Valley fever virus in thermochemically inactivated sheep sera. , 2010, Vector borne and zoonotic diseases.

[128]  Y. Stram,et al.  Epidemiological Investigation of Bovine Ephemeral Fever Outbreaks in Israel , 2010, Veterinary medicine international.

[129]  S. D. Boer,et al.  Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector. , 2010, Vaccine.

[130]  M. Bouloy,et al.  Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention , 2010, Veterinary research.

[131]  G. Flachowsky,et al.  Assessment of Reference Values for Copper and Zinc in Blood Serum of First and Second Lactating Dairy Cows , 2010, Veterinary medicine international.

[132]  B. Bosch,et al.  Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge. , 2010, Vaccine.

[133]  S. D. Boer,et al.  Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus. , 2010, Vaccine.

[134]  Harold A. Mooney,et al.  Livestock in a Changing Landscape, Volume 1: Drivers, Consequences, and Responses; Livestock in a Changing Landscape, Volume 2: Experiences and Regional Perspectives , 2010 .

[135]  R. Mandell,et al.  A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge , 2009, Virology.

[136]  Dina M Fonseca,et al.  Evidence for regular ongoing introductions of mosquito disease vectors into the Galápagos Islands , 2009, Proceedings of the Royal Society B: Biological Sciences.

[137]  D. Holman,et al.  A Complex Adenovirus-Vectored Vaccine against Rift Valley Fever Virus Protects Mice against Lethal Infection in the Presence of Preexisting Vector Immunity , 2009, Clinical and Vaccine Immunology.

[138]  A. McElroy,et al.  Development of a RVFV ELISA that can distinguish infected from vaccinated animals , 2009, Virology Journal.

[139]  S. Kamal Pathological studies on postvaccinal reactions of Rift Valley fever in goats , 2009, Virology Journal.

[140]  M. Habjan,et al.  Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus. , 2009, Virology.

[141]  K. Morita,et al.  Development and Evaluation of a Real-Time Reverse Transcription-Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Rift Valley Fever Virus in Clinical Specimens , 2009, Journal of Clinical Microbiology.

[142]  F. Weber,et al.  Electron Cryo-Microscopy and Single-Particle Averaging of Rift Valley Fever Virus: Evidence for GN-GC Glycoprotein Heterodimers , 2009, Journal of Virology.

[143]  M. Heise,et al.  An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus , 2009, Epidemiology and Infection.

[144]  M. Pepin,et al.  Rift valley fever , 2009, Definitions.

[145]  E. Scholte,et al.  Accidental importation of the mosquito Aedes albopictus into the Netherlands: a survey of mosquito distribution and the presence of dengue virus , 2008, Medical and veterinary entomology.

[146]  W. Van Bortel,et al.  Emerging Pests and Vector-borne Diseases in Europe , 2008, Emerging Infectious Diseases.

[147]  P. Roy,et al.  Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins , 2008, Virology Journal.

[148]  R. Breiman,et al.  Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo. , 2008, Veterinary microbiology.

[149]  T. Ksiazek,et al.  Rift Valley Fever Virus Lacking the NSs and NSm Genes Is Highly Attenuated, Confers Protective Immunity from Virulent Virus Challenge, and Allows for Differential Identification of Infected and Vaccinated Animals , 2008, Journal of Virology.

[150]  M. Rostal,et al.  Prevalence of antibodies against Rift Valley fever virus in Kenyan wildlife , 2007, Epidemiology and Infection.

[151]  A. M. Kilpatrick,et al.  A quantitative risk assessment of West Nile virus introduction into Barbados. , 2007, The West Indian medical journal.

[152]  T. Ksiazek,et al.  Highly Sensitive and Broadly Reactive Quantitative Reverse Transcription-PCR Assay for High-Throughput Detection of Rift Valley Fever Virus , 2007, Journal of Clinical Microbiology.

[153]  J. Coetzer,et al.  Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants. , 2007, Veterinary microbiology.

[154]  S. Gerrard,et al.  The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection. , 2007, Virology.

[155]  A. A. van Dijk,et al.  Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA. , 2007, Journal of virological methods.

[156]  G. Viljoen,et al.  Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever. , 2006, Vaccine.

[157]  S. Nichol,et al.  Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins , 2006, Virology.

[158]  C. Peters,et al.  NSm and 78-Kilodalton Proteins of Rift Valley Fever Virus Are Nonessential for Viral Replication in Cell Culture , 2006, Journal of Virology.

[159]  M. Saad,et al.  Adverse response of non‐indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine , 2006, Journal of medical virology.

[160]  A. McElroy,et al.  Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. , 2006, Vaccine.

[161]  Andrew J Tatem,et al.  Global traffic and disease vector dispersal. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[162]  Shinji Makino,et al.  Rescue of Infectious Rift Valley Fever Virus Entirely from cDNA, Analysis of Virus Lacking the NSs Gene, and Expression of a Foreign Gene , 2006, Journal of Virology.

[163]  J. Pawęska,et al.  Validation of IgG-sandwich and IgM-capture ELISA for the detection of antibody to Rift Valley fever virus in humans. , 2005, Journal of virological methods.

[164]  G. H. Gerdes Rift Valley fever. , 2004, Revue scientifique et technique.

[165]  J. Pawęska,et al.  IgG-sandwich and IgM-capture enzyme-linked immunosorbent assay for the detection of antibody to Rift Valley fever virus in domestic ruminants. , 2003, Journal of virological methods.

[166]  A. Kemp,et al.  The 2000 epidemic of Rift Valley fever in Saudi Arabia: mosquito vector studies , 2002, Medical and veterinary entomology.

[167]  Christian Drosten,et al.  Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR , 2002, Journal of Clinical Microbiology.

[168]  L. Marrama,et al.  Use of Reverse Transcriptase PCR in Early Diagnosis of Rift Valley Fever , 2002, Clinical and Vaccine Immunology.

[169]  M. Bouloy,et al.  Quantitative Real-Time PCR Detection of Rift Valley Fever Virus and Its Application to Evaluation of Antiviral Compounds , 2001, Journal of Clinical Microbiology.

[170]  J. Mouchet,et al.  African malaria vectors in European aircraft , 2001, The Lancet.

[171]  R. Eritja,et al.  Aircraft-mediated mosquito transport: new direct evidence. , 2000, Journal of the American Mosquito Control Association.

[172]  A. Kohl,et al.  The S Segment of Rift Valley Fever Phlebovirus (Bunyaviridae) Carries Determinants for Attenuation and Virulence in Mice , 2000, Journal of Virology.

[173]  C. Peters,et al.  Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience. , 1999, Vaccine.

[174]  E. C. Anderson,et al.  The prevalence of antibody to the viruses of bovine virus diarrhoea, bovine herpes virus 1, rift valley fever, ephemeral fever and bluetongue and to Leptospira sp in free-ranging wildlife in Zimbabwe , 1998, Epidemiology and Infection.

[175]  M. Bouloy,et al.  Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. , 1997, Virus research.

[176]  M. Turell,et al.  Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. , 1995, The American journal of tropical medicine and hygiene.

[177]  R. Romi,et al.  Source and spread of Aedes albopictus in the Veneto region of Italy. , 1994, Journal of the American Mosquito Control Association.

[178]  J. Saluzzo,et al.  Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine. , 1990, Vaccine.

[179]  J. Suzich,et al.  Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins. , 1989, Virology.

[180]  K. Linthicum,et al.  Observations on the dispersal and survival of a population of Aedes lineatopennis (Ludlow) (Diptera: Culicidae) in Kenya , 1985 .

[181]  C. Peters,et al.  Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. , 1985, The Journal of general virology.

[182]  F. Davies,et al.  Rift Valley Fever in Kenya: the presence of antibody to the virus in camels (Camelus dromedarius) , 1985, Journal of Hygiene.

[183]  M. Eisa Preliminary survey of domestic animals of the Sudan for precipitating antibodies to Rift Valley fever virus , 1984, Journal of Hygiene.

[184]  R. Swanepoel,et al.  Protein synthesis in Rift Valley fever virus-infected cells. , 1984, Virology.

[185]  D. Pedgley Windborne spread of insect-transmitted diseases of animals and man , 1983 .

[186]  R. Sellers,et al.  Rift Valley fever, Egypt 1977: disease spread by windborne insect vectors? , 1982, Veterinary Record.

[187]  F. Davies,et al.  Experimental infection of the African buffalo with the virus of Rift Valley fever , 1981, Tropical Animal Health and Production.

[188]  C. Peters,et al.  Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep. , 1980, American journal of veterinary research.

[189]  B. Barnard,et al.  An inactivated rift valley fever vaccine. , 1977, Journal of the South African Veterinary Association.

[190]  B. Mcintosh,et al.  Rift Valley fever. 2. Attempts to transmit virus with seven species of mosquito. , 1973, Journal of the South African Veterinary Medical Association.

[191]  A. Pini,et al.  The immunity induced in cattle and sheep by inoculation of neurotropic or pantropic Rift Valley fever viruses. , 1967, Research in veterinary science.

[192]  C. Gibbs,et al.  The development of a formalin-killed Rift Valley fever virus vaccine for use in man. , 1962, Journal of immunology.

[193]  Smithburn Kc Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine. , 1949, British journal of experimental pathology.

[194]  J. Slingenbergh Ecological and epidemiological roles of camels : lessons from existing and emerging viral infections , 2016 .

[195]  The path to greener pastures Pastoralism, the backbone of the world’s drylands , 2016 .

[196]  M. Bouslikhane 2015 – Africa – OIE Regional Commission – Bouslikhane CROSS BORDER MOVEMENTS OF ANIMALS AND ANIMAL PRODUCTS AND THEIR RELEVANCE TO THE EPIDEMIOLOGY OF ANIMAL DISEASES IN AFRICA , 2015 .

[197]  Heinz Mehlhorn,et al.  World Organisation for Animal Health (OIE) , 2015 .

[198]  S. More,et al.  Scientific Opinion on peste des petits ruminants , 2015 .

[199]  E. Scholte,et al.  Mosquito collections on incoming intercontinental flights at Schiphol International airport, the Netherlands, 2010-2011 , 2014 .

[200]  P. Marianneau,et al.  European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus. , 2013, Journal of virological methods.

[201]  Deena M. Abdelgadir,et al.  Transovarian transmission of Rift Valley Fever Virus by two species of mosquitoes in Khartoum State (Sudan): Aedes vexans (Meigen) and Culex quinquefasciatus (Say) , 2013 .

[202]  E. Scholte,et al.  Findings and control of two invasive exotic mosquito species, Aedes albopictus and Ae. atropalpus (Diptera: Culicidae) in the Netherlands, 2011. , 2012 .

[203]  Virology Journal BioMed Central , 2009 .

[204]  Y. Tsuda,et al.  Results of mosquito collection from international aircrafts arriving at Narita International Airport, Japan and mosquito surveillance at the airport , 2007 .

[205]  K. C. Smithburn RIFT VALLEY FEVER; THE NEUROTROPIC ADAPTATION OF THE VIRUS AND THE EXPERIMENTAL USE OF THIS MODIFIED VIRUS AS A VACCINE. , 2007 .

[206]  J. Coetzer,et al.  Infectious diseases of livestock , 2004 .

[207]  F. Schaffner Mosquitoes in used tyres in Europe: species list and larval key , 2003 .

[208]  L. P. Lounibos,et al.  Invasions by insect vectors of human disease. , 2002, Annual review of entomology.

[209]  N. Gratz,et al.  Why aircraft disinsection? , 2000, Bulletin of the World Health Organization.

[210]  R. Russell,et al.  In-flight disinsection as an efficacious procedure for preventing international transport of insects of public health importance. , 1989, Bulletin of the World Health Organization.

[211]  D. Chadee,et al.  Arthropods collected from aircraft at Piarco International Airport, Trinidad, West Indies. , 1983 .

[212]  I. Imam,et al.  An epidemic of Rift Valley fever in Egypt. 2. Isolation of the virus from animals. , 1979, Bulletin of the World Health Organization.